7487 Results

People

  1. Brennan
    Brennan
  2. Danishefsky
    Danishefsky
  3. Larson
    Larson
  4. Scheinberg
    Scheinberg
  5. Fuks
    Fuks
  6. Rosen
    Rosen
  7. Hricak
    Hricak
  8. Pasternak
    Pasternak
  9. Sadelain
    Sadelain
  10. Scardino
    Scardino

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)
  7. Radiology, Department of (1814)
  8. Hematologic Malignancies Research (1617)
  9. Hematologic Malignancies, Division of (1517)
  10. Center for Molecular Imaging and Biotechnology (1341)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Automatic segmentation refined, multiple slice-wise voting based classification of tumors from MRI
    Meeting Abstract

    Veeraraghavan, H.; Lakhman, Y.; Feier, D.; Vargas, H.; Hricak, H.; Deasy, J.; Sala, E.
    Medical Physics (2015)

    Fulltext@MSK | Save
  • Targeted alpha-particle therapy of disseminated prostate cancer with 225-Actinium-11B6
    Meeting Abstract

    Ulmert, D.; Abou, D.; Lilja, H.; Larson, S.; Thorek, D.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • First in human (89)Zr-Df-IAB2M antiprostate specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer
    Meeting Abstract

    Pandit-Taskar, N.; O'Donoghue, J.; Martinez, D.; Lyashchenko, S.; Carrasquillo, J.; Durack, J.; Keppler, J.; Scher, H.; Larson, S.; Morris, M.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Rest and stress Rb-82 PET myocardial perfusion imaging as a predictor of perioperative cardiac events in cancer patients
    Meeting Abstract

    Fox, J.; Gupta, D.; Yu, A.; Gandikota, N.; Larson, S.; Schoder, H.; Strauss, H. W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Predicting bone marrow toxicity from treatment with I-131 sodium iodide (NaI)
    Meeting Abstract

    Edlibe, M.; Deal, A.; Phillips, M.; Pentlow, K.; Tuttle, R.; Larson, S.; Sheikh, A.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Wholebody clearance of three (89)Zr labeled antibodies: Differences between PET based and whole body probe based clearance
    Meeting Abstract

    Beylergil, V.; Pandit-Taskar, N.; Larson, S.; Morris, M.; Danila, D. C.; Bander, N.; Fine, B.; Carrasquillo, J.; Weber, W.; O'Donoghue, J.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C. S.; Riviere, I.; Bernal, Y.; Wang, X. Y.; Purdon, T.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Primary high-grade myxofibrosarcoma/pleomorphic malignant fibrous histiocytoma: Percent myxoid component to improve outcome prediction
    Meeting Abstract

    Lee, A. Y.; Agaram, N. P.; Qin, L. X.; Brennan, M. F.; Singer, S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save